With trading days like yesterday it’s tough to keep the faith.
After days like that I always like to think about my worst case scenario in case Cydy succeeds only marginally.

My worst case scenario being that we’ll end up with an approved combo HIV therapy for the US market.

And either we partner up getting 50% royalties and we’ll end up with 1 billion cydy shares outstanding (I do not think so, but worst case) or
We’re “forced” to take the route of doing it alone ending up with 2 billion oustanding shares.

Worst case sales projection 1.7 billion $ (according to presentation with $35,000 price of Leronlimab)

Net profit 15% of sales/royalties.

Price/earnings =10

Results:

Partnering (1.7 billion x 50% x 15% x 10 ) / 1 billion = $ 1.275 pps
Alone (1.7 billion x 15% x 10) / 2 billion = $ 1.275 pps

I know it’s not a very sophisticated model, I know.

Would I risk losing $ 0.31 for the prospect of making $1.275 worst case?
The market is factually pricing in a probability of 24.3% for my worst case scenario.
I believe our chances are much higher than that.
Being unable to add I’ll continue to hold.